• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
DCPH

DCPH

Deciphera Pharmaceuticals, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD25.59

+0.02 (+0.08%)

Company Profile

CEO

Steven L. Hoerter

IPO Date

2017-09-28

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

US

Market Metrics

Open

$25.56

Prev. Close

$25.57

Day Low

$25.56

Day High

$25.61

52W Low

$9.90

52W High

$25.61

Market Cap

$2.21B

Volume

1.57M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

32.7%

Avg Negative

20.0%

Avg Neutral

47.4%

News Feed

Deciphera (DCPH) Q2 Loss Wider Than Expected, Revenues Beat

Zacks Investment Research·8/4/2021·↓ negative

Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steve Hoerter on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/4/2021·↓ negative

2 Beaten-Down Biotech Stocks That Could Bounce Back

The Motley Fool·7/27/2021·↑ positive

Deciphera (DCPH) Begins Dosing in Study on Cancer Candidate

Zacks Investment Research·7/1/2021·↑ positive

Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Down 10.8% Since Last Earnings Report?

Zacks Investment Research·6/3/2021·↓ negative

Near a 2-Year Low, Is Deciphera Pharmaceuticals a Buy?

The Motley Fool·5/13/2021·↑ positive

Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steven Hoerter on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/10/2021·↓ negative

Deciphera (DCPH) Q1 Loss Narrower Than Expected, Revenues Beat

Zacks Investment Research·5/5/2021·↓ negative

Deciphera Pharmaceuticals, Inc. Announces First Quarter 2021 Financial Results

Business Wire·5/4/2021·↑ positive

Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference

Business Wire·3/2/2021·↑ positive